Embolization device constructed from expansile polymer

US10226258B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10226258-B2
Application numberUS-201715635046-A
CountryUS
Kind codeB2
Filing dateJun 27, 2017
Priority dateJun 15, 2006
Publication dateMar 12, 2019
Grant dateMar 12, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.

First claim

Opening claim text (preview).

We claim: 1. An occlusion device comprising: an elongated hydrogel having a solid mass and a substantially continuous length, and a flexible carrier member situated around the elongated hydrogel, wherein the elongated hydrogel includes a polyether macromer, and wherein the elongated hydrogel is configured to expand upon contact with an aqueous liquid. 2. The occlusion device of claim 1 , wherein the polyether macromer is poly(ethylene glycol) di-acrylamide, poly(ethylene glycol) di-acrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, a derivative thereof, or a combinations thereof. 3. The occlusion device of claim 2 , wherein the polyether macromer is poly(ethylene glycol) di-acrylamide. 4. The occlusion device of claim 1 , wherein the flexible carrier member is a coil or microcoil. 5. The occlusion device of claim 1 , wherein the flexible carrier member includes at least one gap configured to allow the elongated hydrogel to expand into the at least one gap. 6. The occlusion device of claim 4 , wherein the at least one gap is between 0.00025″ and 0.005″. 7. The occlusion device of claim 1 , further comprising a monomer including at least one pH sensitive ionizable functional group. 8. The occlusion device of claim 7 , wherein the at least one pH sensitive ionizable functional group includes a basic group or an acidic group. 9. The occlusion device of claim 8 , wherein the basic group comprises an amine, derivatives thereof, or combinations thereof. 10. The occlusion device of claim 8 , wherein the basic group is configured to be deprotonated at pHs greater than the pKa or protonated at pHs less than the pKa of the functional group. 11. The occlusion device of claim 8 , wherein the acidic group comprises a carboxylic acid, derivatives thereof, or combinations thereof. 12. The occlusion device of claim 8 , wherein the acidic group is configured to be protonated at pHs less than the pKa or de-protonated at pHs greater than the pKa of the functional groups. 13. The occlusion device of claim 7 , wherein the monomer is acrylic acid, methacrylic acid, or a salt thereof. 14. The occlusion device of claim 1 , wherein the elongated hydrogel is substantially free of acrylamide. 15. The occlusion device of claim 1 , wherein the polyether macromer is cross-linked with at least one ethylenically unsaturated compound. 16. The occlusion device of claim 1 , wherein the polyether macromer is cross-linked with N,N′-methylenebisacrylamide, derivatives thereof, or combinations thereof. 17. The occlusion device of claim 1 , wherein the elongated hydrogel comprises a reaction product of a monomer, the polyether macromer, and an initiator. 18. The occlusion device of claim 17 , wherein the initiator is N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, a derivative thereof, or a combination thereof. 19. The occlusion device of claim 1 , wherein the elongated hydrogel is substantially non-resorbable. 20. The occlusion device of claim 1 , wherein the flexible carrier member is metallic or polymeric. 21. The occlusion device of claim 1 , wherein the elongated hydrogel includes pores.

Assignees

Inventors

Classifications

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

  • having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526) · CPC title

  • having a mesh structure (A61B17/1214 takes precedence) · CPC title

  • within an aneurysm · CPC title

  • Coils or wires · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10226258B2 cover?
Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification A61B17/1219. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).